Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Inflammation01:38

Inflammation

Overview
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Associations between serum cholesterol and immunophenotypical characteristics of circulatory B cells and Tregs.

Journal of lipid research·2023
Same author

The association between the number of symptoms and the severity of Post-COVID-Fatigue after SARS-CoV-2 infection treated in an outpatient setting.

Journal of neurology·2023
Same author

Time-Varying Use of Proton Pump Inhibitors and Cognitive Impairment and Dementia: A Real-World Analysis from Germany.

Drugs & aging·2023
Same author

Plasma viscosity, immunoglobulins and risk of cardiovascular disease and mortality: new data and meta-analyses.

Journal of clinical pathology·2023
Same author

Association of Aldosterone with Mortality in the General Population.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2023
Same author

Association between fatigue and cytokine profiles in patients with ischemic stroke.

Frontiers in neurology·2023

相关实验视频

Updated: Jun 3, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

脂蛋白相关脂酶A2增加了C-反应蛋白对一般人群中看似健康的中年男性的风险预测:来自德国南部的一大队的14年随访结果.

Wolfgang Koenig1, Natalie Khuseyinova, Hannelore Löwel

  • 1Department of Internal Medicine II-Cardiology, University of Ulm Medical Center, Robert-Koch Strasse. 8, D-89081 Ulm, Germany. wolfgang.koenig@medizin.uni-ulm.de.

Circulation
|September 29, 2004
PubMed
概括

升高的脂蛋白相关脂酶A2 (Lp-PLA2) 水平预测健康的中年男性未来的冠状动脉事件. 在预测心脏病风险方面,LP-PLA2可能与C-反应蛋白 (CRP) 添加.

更多相关视频

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

High-Density Lipoprotein-Specific Phospholipid Efflux Assay
07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

相关实验视频

Last Updated: Jun 3, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

High-Density Lipoprotein-Specific Phospholipid Efflux Assay
07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

科学领域:

  • 心血管科学 心血管科学
  • 炎症生物学 炎症生物学
  • 生物标志物研究 生物标志物研究

背景情况:

  • 慢性炎症是动脉样硬化的一个关键因素.
  • 与脂蛋白相关的脂酶A2 (Lp-PLA2) 产生促炎产物.
  • Lp-PLA2主要由单细胞和巨细胞产生.

研究的目的:

  • 调查Lp-PLA2水平对冠状动脉事件的预测价值.
  • 评估Lp-PLA2与心血管风险因素之间的关系.
  • 为了确定Lp-PLA2是否能够独立于C反应蛋白 (CRP) 预测冠状动脉事件.

主要方法:

  • 使用ELISA测量了934名健康男性 (45-64岁) 的血Lp-PLA2度.
  • 参与者在14年内进行了冠状动脉事件的跟踪.
  • 考克斯的比例危险模型被用于评估风险,并对混因素进行调整.

主要成果:

  • 在经历冠状动脉事件的男性中观察到较高的Lp-PLA2基线水平.
  • Lp-PLA2与总胆固醇和年龄正相关.
  • 在调整后,Lp-PLA2的1-SD增加与冠状动脉事件的风险增加23%有关.

结论:

  • 升高的Lp-PLA2水平预示着看似健康的中年男性未来的冠状动脉事件.
  • Lp-PLA2可以独立于CRP预测风险.
  • 在预测冠心病风险方面,Lp-PLA2和CRP可能具有相加的作用.